StonvexLoading…
StonvexCore line items from GILT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $451.66M | $305.45M | $266.09M | $239.84M |
Operating Income | $23.44M | $27.70M | $28.09M | $9.95M |
Net Income | $20.72M | $24.85M | $23.50M | $-5.93M |
EPS (Diluted) | $0.34 | $0.44 | $0.41 | $-0.10 |
Total Assets | $746.05M | $429.75M | $426.89M | $385.41M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $168.91M | $119.38M | $103.96M | $86.59M |
Free Cash Flow OCF − CapEx | $9.19M | $25.06M | $21.20M | $-1.98M |
Shares Outstanding | 73.83M | 57.02M | 57.02M | 56.61M |